Inflammation and drug idiosyncrasy - Is there a connection?

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 1, 2003, Pages 1-8

  Roth, Robert A ^a   Luyendyk, James P ^a   Maddox, Jane F ^a   Ganey, Patricia E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHYDRAZIDE; AFLATOXIN B1; ALLYL ALCOHOL; CHLORPROMAZINE; CLOZAPINE; FAMOTIDINE; HALOTHANE; HISTAMINE H2 RECEPTOR ANTAGONIST; ISONIAZID; MONOCROTALINE; NEUROLEPTIC AGENT; TROGLITAZONE;

DNA POLYMORPHISM; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG METABOLISM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS;

DRUG HYPERSENSITIVITY; ENDOTOXINS; HEPATITIS, TOXIC; HUMANS; INFLAMMATION;

EID: 0141519565     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041624     Document Type: Review

References (45)

1. Alden C, Lin J, and Smith P (2003) Predictive toxicology technology for avoiding idiosyncratic liver injury. Preclinica May/June: 27-35.
2. Ament PW, Roth JD, and Fox CJ (1994) Famotidine-induced mixed hepatocellular jaundice. Ann Pharmacotherapy 28:40-42.
3. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, and Schwartz DA (2000) Tlr4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191.
4. Barton CC, Barton EX, Ganey PE, Kunkel SL, and Roth RA (2001) Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor-α. Hepatology 33:66-73.
5. Barton CC, Ganey PE, and Roth RA (2000a) Lipopolysaccharide augments aflatoxin B1-induced liver injury through neutrophil-dependent and independent mechanisms. Toxicol Sci 58:208-215.
6. 1-induced liver injury. Toxicol Sci 55:444-452.
7. Beutler F (2000) Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20-26.
8. Bianchi L and Scheuer PJ (1974) Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Lancet 1:854-857.
9. Buchweitz JP, Ganey PE, Bursian SJ, and Roth RA (2002) Underlying endototoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? J Pharmacol Exp Ther 300:460-467.
10. Caroff SN (1980) The neuroleptic malignant syndrome. J Clin Psychiatry 41:79-83.
11. Fanucchi MV, Hotchkiss JA, and Harkema JR (1998) Endotoxin potentiates ozone-induced mucous cell metaplasia in rat nasal epithelium. Toxicol Appl Pharmacol 152:1-9.
12. Fukano M, Amano S, Sato J, Yamamoto K, Adachi H, Okabe H, Fujiyama Y, and Bamba T (2000) Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination. Hum Pathol 31:250-253.
13. Ganey PE, Barton Y-W, Kinser S, Sneed RA, Barton CC, and Roth RA (2001) Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide. Toxicol Appl Pharmacol 174:113-121.
14. Goldman SA (1996) Lithium and neuroleptics in combination: the spectrum of neurotoxicity. Psychopharmacol Bull 32:299-309.
15. Gurumurthy P, Krishnamurthy MS, Nazareth O, Parthasarathy R, Sarma GR, Somasundaram PR, Tripathy SP, and Ellard GA (1984) Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. Am Rev Respir Dis 129:58-61.
16. Hashimoto F, Davis RL, and Egli D (1994) Hepatitis following treatments with famotidine and then cimetidine. Ann Pharmacother 28:37-39.
17. Ishak KG and Irey NS (1972) Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 93:283-304.
18. Jimenez-Saenz M, Arguelles-Arias F, Herrerias-Gutierrez JM, and Duran-Quintana JA (2000) Acute cholestatic hepatitis in a child treated with famotidine. Am J Gastroenterol 95:3665-3666.
19. Kitteringham NR, Kenna JG, and Park BK (1995) Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. Br J Clin Pharmacol 40:379-386.
20. Khouri MR, Saul SH, Dlugosz AA, and Soloway RD (1987) Hepatocanalicular injury associated with vitamin A derivative etretinate. An idiosyncratic hypersensitivity reaction. Dig Dis Sci 32:1207-1211.
21. Larrey D and Erlinger S (1988) Drug-induced cholestasis. Baillieres Clin Gastroenterol 2:423-452.
22. Lazarou J, Pomeranz BH, and Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients-a meta-analysis of prospective studies. J Am Med Assoc 279:1200-1205.
23. Lind RC, Gandolfi AJ, Sipes IG, and Brown BR (1984) The involvement of endotoxin in halothane-associated liver injury. Anesthesiol 61:544-550.
24. Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, and Roth RA (2003) Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther 307:1227-1234.
25. 1 hepatotoxicity: benchmark dose analysis for markers of liver injury. Toxicol Sci 68:220-225.
26. Meltzer HY, Cola PA, and Parsa M (1996) Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 15:395-405.
27. Moradpour D, Altorfer J, Flury R, Greminger P, Meyenberger C, Jost R, and Schimd M (1994) Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 20:1437-1441.
28. Murphy EJ, Davern TJ, Shakil AO, Shick L, Masharani U, Chow H, Freise C, Lee WM, Bass NM, and the Acute Liver Failure Study Group (2000) Troglitazone-induced Fulminant Hepatic Failure. Dig Dis Sci 45:549-553.
29. Nankivell BJ, Bhandari PK, and Koller LJ (1994) Rhabdomyolysis induced by thioridazine. Br Med J 309:378.
30. Njoku DB, Greenberg RS, Bourdi M, Borkowf CB, Dake EM, Martin JL, and Pohl LR (2002) Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth Analg 94:243-249.
31. Ramrakhiani S, Brunt EM, and Bacon BR (1998) Possible cholestatic injury from ranitidine with a review of the literature. Am J Gastroenterol 93:822-826.
32. Ribeiro JM, Lucas M, Baptista A, and Victorino RMM (2000) Fatal hepatitis associated with ranitidine. Am J Gastroenterol 95:559-560.
33. Roth RA, Harkema JR, Pestka JP, and Ganey PE (1997) Is exposure to bacterial endotoxin a determinant of susceptibility from xenobiotic agents? Toxicol Appl Pharmacol 147:300-311.
34. Rumbeiha WK, Fitzgerald SD, Braselton WE, Roth RA, and Kaneene JB (2000) Potentiation of mercury-induced nephrotoxicity by endotoxin in the Sprague-Dawley rat. Toxicology 149:75-87.
35. Singapore Tuberculosis Service/British Medical Research Council (1977) Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. Am Rev Respir Dis 116:807-820.
36. Sneed RA, Buchweitz JP, Jean PA, and Ganey PE (2000) Pentoxifylline attenuates bacterial lipopolysaccharide-induced enhancement of allyl alcohol hepatotoxicity. Toxicol Sci 56:203-210.
37. Sneed RA, Grimes SD, Schultze AE, Brown AP, and Ganey PE (1997) Lipopolysaccharide enhances the hepatotoxicity of allyl alcohol. Toxicol Appl Pharmacol 144:77-87.
38. Stevens GJ, Payton M, Sim E, and McQueen CA (1999) N-Acetylation of the heterocyclic amine batracylin by human liver. Drug Metab Dispos 27:966-971.
39. Uetrecht JP (1999) New concepts in immunology relevant to idiosyncratic drug reactions: The "danger hypothesis" and innate immune system. Chem Res Toxicol 12:387-395.
40. Weber WW (1999) Populations and genetic polymorphisms. Mol Diagn 4:299-307.
41. Weber WW, Hein DW, Litwin A, and Lower GM (1983) Relationship of acetylator status to isoniazid toxicity, lupus erythematosus and bladder cancer. Fed Proc 42:3086-3091.
42. Yee SB, Copple BL, Ganey PE, and Roth RA (2002) The temporal relationship between bacterial lipopolysaccharide and monocrotaline exposures influences toxicity: shift in response from hepatotoxicity to nitric oxide-dependent lethality. J Toxicol Environ Health 65:961-976.
43. Yee SB, Kinser S, Hill DA, Barton CC, Hotchkiss JA, Harkema JR, Ganey PE, and Roth RA (2000) Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline. Toxicol Appl Pharmacol 166:173-185.
44. Zhou HR, Harkema JR, Hotchkiss JA, Yan D, Roth RA, and Pestka JJ (2000) Lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol) synergistically induce apoptosis in murine lymphoid organs. Toxicol Sci 53:253-263.
45. Zimmerman HJ (1993) Hepatotoxicity. Dis Mon 39:675-787.